ResApp Health Limited

ASX:RAP 주식 보고서

시가총액: AU$176.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

ResApp Health 관리

관리 기준 확인 4/4

주요 정보

Tony Keating

최고 경영자

AU$318.8k

총 보상

CEO 급여 비율80.2%
CEO 임기7.2yrs
CEO 소유권1.2%
경영진 평균 재임 기간4.4yrs
이사회 평균 재임 기간3.3yrs

최근 관리 업데이트

Recent updates

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Dec 31
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Aug 26
Is ResApp Health (ASX:RAP) In A Good Position To Invest In Growth?

Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

May 08
Here's Why We're Watching ResApp Health's (ASX:RAP) Cash Burn Situation

Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Feb 25
Analysts Are Optimistic We'll See A Profit From ResApp Health Limited (ASX:RAP)

Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

Dec 23
Companies Like ResApp Health (ASX:RAP) Are In A Position To Invest In Growth

CEO 보상 분석

Tony Keating 의 보수는 ResApp Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2022AU$319kAU$256k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$7m

Jun 30 2021AU$358kAU$256k

-AU$7m

Mar 31 2021n/an/a

-AU$7m

Dec 31 2020n/an/a

-AU$8m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$449kAU$256k

-AU$8m

Mar 31 2020n/an/a

-AU$7m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$290kAU$256k

-AU$5m

Mar 31 2019n/an/a

-AU$6m

Dec 31 2018n/an/a

-AU$7m

Sep 30 2018n/an/a

-AU$7m

Jun 30 2018AU$296kAU$256k

-AU$7m

Mar 31 2018n/an/a

-AU$6m

Dec 31 2017n/an/a

-AU$6m

Sep 30 2017n/an/a

-AU$8m

Jun 30 2017AU$1mAU$256k

-AU$10m

Mar 31 2017n/an/a

-AU$10m

Dec 31 2016n/an/a

-AU$9m

Sep 30 2016n/an/a

-AU$6m

Jun 30 2016AU$537kAU$189k

-AU$3m

보상 대 시장: Tony's total compensation ($USD214.17K) is about average for companies of similar size in the Australian market ($USD283.12K).

보상과 수익: Tony's compensation has been consistent with company performance over the past year.


CEO

Tony Keating

7.2yrs

테뉴어

AU$318,770

보상

Dr. Anthony James Keating, also known as Tony, has been Chief Executive Officer and Managing Director of ResApp Health Limited since July 2, 2015. Dr. Keating served as a Director of Commercial Engagement...


리더십 팀

이름위치테뉴어보상소유권
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Al Lunar
Vice President of Finance1.7yrs데이터 없음데이터 없음
Scott Savage
Vice President of Technology & Productno data데이터 없음데이터 없음
Nicki Farley
Company Secretary9.8yrs데이터 없음데이터 없음
Clas Källander
Founder and Director of R&D of Cavidi ABno dataAU$108.72k데이터 없음
Mike Connell
VP of Commercialno data데이터 없음데이터 없음
Paul Porter
Scientific Advisorno data데이터 없음데이터 없음

4.4yrs

평균 재임 기간

경험이 풍부한 관리: RAP's management team is considered experienced (4.4 years average tenure).


이사회 구성원

이름위치테뉴어보상소유권
Anthony Keating
CEO, MD & Director7.2yrsAU$318.77k1.19%
A$ 2.1m
Brian Leedman
Executive Director of Corporate Affairs & Executive Director1.3yrsAU$200.07k0.29%
A$ 512.9k
Paul Porter
Scientific Advisorno data데이터 없음데이터 없음
Michael Stein
Non-Executive Director2.4yrsAU$55.00k데이터 없음
Roger Aston
Non-Executive Chairman7.2yrsAU$90.00k0.034%
A$ 59.4k
Joseph Kvedar
Member of Industry Advisory Board3.3yrs데이터 없음데이터 없음
Christopher Ntoumenopoulos
Non-Executive Director7.7yrsAU$55.00k0.058%
A$ 102.5k
Naomi Fried
Member of Industry Advisory Board3.3yrs데이터 없음데이터 없음
Philip Currie
Member of Scientific Advisory Board5.1yrs데이터 없음데이터 없음
Scott Claxton
Member of Scientific Advisory Board3.7yrs데이터 없음데이터 없음
Elizabeth Talbot
Member of Scientific Advisory Boardless than a year데이터 없음데이터 없음
Catherine Bennett
Member of Scientific Advisory Boardless than a year데이터 없음데이터 없음

3.3yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: RAP's board of directors are considered experienced (3.3 years average tenure).